Ridnour, Lisa A.; Cheng, Robert Y. S.; Kedei, Noemi; Somasundaram, Veena; Bhattacharyya, Dibyangana D.; Basudhar, Debashree; Wink, Adelaide L.; Walke, Abigail J.; Kim, Caleb; Heinz, William F.; Edmondson, Elijah F.; Butcher, Donna O.; Warner, Andrew C.; Dorsey, Tiffany H.; Pore, Milind; Kinders, Robert J.; Lipkowitz, Stanley; Bryant, Richard J.; Rittscher, Jens; Wong, Stephen T. C.; Hewitt, Stephen M.; Chang, Jenny C.; Shalaby, Aliaa; Callagy, Grace M.; Glynn, Sharon A.; Ambs, Stefan; Anderson, Stephen K.; McVicar, Daniel W.; Lockett, Stephen J.; Wink, David A.

Tumor necrosis factor related apoptosis inducing ligand (TRAIL)-induced cytokine production in TNBC promotes neutrophil chemotaxis and immune suppression

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Pyruvate dehydrogenase operates as an intramolecular nitroxyl generator during macrophage metabolic reprogramming

NATURE COMMUNICATIONS

IF15.7

2023-08-2211

OAAI

Interferon-gamma is quintessential for NOS2 and COX2 expression in ER- breast tumors that lead to poor outcome

CELL DEATH & DISEASE

IF9.6

2023-05-115

OAAI

Pyruvate Dehydrogenase Operates as an Intramolecular Nitroxyl Generator During Macrophage Metabolic Reprogramming

JOURNAL OF IMMUNOLOGY

IF3.4

2023-05-010

IL-27 induces an IFN-like signature in murine macrophages which in turn modulate colonic epithelium

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-04-203

OAAI

Interferon-gamma induces NOS2 and COX2 in ER-breast cancer that drives increase metastatic potential

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Tumor necrosis factor related apoptosis inducing ligand (TRAIL) induces cytokine release via the alternative NFKB2 pathway in triple negative breast cancer cells (TNBC) and modulates neutrophil chemotaxis

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Multiplex proteomics profiling with the imaging mass cytometry (IMC) identifies immune cell phenotypes associated with high NOS2/COX2 expression in ER- negative and TNBC patients

CANCER RESEARCH

IF16.6

2023-04-040

PRE

New nitrosyl ruthenium complexes with combined activities for multiple cardiovascular disorders

DALTON TRANSACTIONS

IF3.3

2023-01-016

Targeting Nitric Oxide: Say NO to Metastasis

靶向一氧化氮: 对转移说不

CLINICAL CANCER RESEARCH

IF10.2

2022-12-1516

OAAI

Systemic Nos2 Depletion and Cox inhibition limits TNBC disease progression and alters lymphoid cell spatial orientation and density

系统性Nos2耗竭和Cox抑制限制了TNBC疾病的进展，并改变了淋巴样细胞的空间方向和密度

REDOX BIOLOGY

IF11.9

2022-12-0110

Somasundaram, Veena; Ridnour, Lisa A.; Cheng, Robert Ys; Walke, Abigail J.; Kedei, Noemi; Bhattacharyya, Dibyangana D.; Wink, Adelaide L.; Edmondson, Elijah F.; Butcher, Donna; Warner, Andrew C.; Dorsey, Tiffany H.; Scheiblin, David A.; Heinz, William; Bryant, Richard J.; Kinders, Robert J.; Lipkowitz, Stanley; Wong, Stephen T. C.; Pore, Milind; Hewitt, Stephen M.; McVicar, Daniel W.; Anderson, Stephen K.; Chang, Jenny; Glynn, Sharon A.; Ambs, Stefan; Lockett, Stephen J.; Wink, David A.

HNO Protects the Myocardium against Reperfusion Injury, Inhibiting the mPTP Opening via PKCε Activation

HNO通过pkc ε 活化抑制mPTP开放保护心肌免受再灌注损伤

ANTIOXIDANTS

IF6.6

2022-02-1415

OAAI

Nitric Oxide and Cancer: When to Give and When to Take Away?

一氧化氮和癌症: 什么时候给予，什么时候带走？

INORGANIC CHEMISTRY

IF4.7

2021-10-2531

PREAI